Control of Microvascular Tone in Traumatic Brain Injury

创伤性脑损伤中微血管张力的控制

基本信息

  • 批准号:
    7407435
  • 负责人:
  • 金额:
    $ 33.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-03-10 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A major event following brain trauma is the loss of autoregulatory capacity of brain microvessels which results in sustained hypoperfusion and improper delivery of vital metabolites to brain tissue. Previously we established that the sustained hypoperfusion and the lack of autoregulatory capacity post trauma are largely due to the capability of injured cells in the vascular wall and in other brain compartments to synthesize and maintain excessive amounts of endothelin-1 (ET-1). ET-1, as well as its two isoforms ET-2 and ET-3, exert signal-transducing, vasoconstrictor effects through their only known receptors ET-RA and ET-RB. Although activation of both receptors is known to cause vasoconstriction in both in vitro preparations and non-neural tissues, little is known of their role in the injured brain and the development of secondary cell injury. In fact the role of ET-RA and ET-RB in vasoconstriction and their pharmacological manipulation to prevent cell injury after traumatic brain injury (TBI) have never been studied. We propose that upregulation of the genes encoding for the synthesis of ET-RA and ET-RB in smooth muscle and endothelium (where they are expressed most abundantly), as well as in other perivascular cells, underlie the enhanced contractility previously observed in the microvascular wall after TBt. In this proposal our specific aims are to: 1) characterize quantitatively in time the expressions of ET- RA and ET- RB (mRNA) in distinct cellular compartments of the vascular wall and surrounding neuropil prior to and after TBI, 2) translationaly inhibit the expression of ET- RA and ET- RB before TBI to improve the impaired microcirculation, and 3) pharmacologically attenuate hypoperfusion post TBI by application of selective antagonists to ET- RA and ET- RB. We will use in situ hybridization to measure mRNA synthesis and in vivo intracerebroventricular application of antisense oligodeoxynucleotides to attenuate ET- RA and ET- RB gene expressions." In tandem use of selective receptor antagonist with the 14C iodoantipyrine technique we will assess antagonist effects on cerebral cortical blood flow. By similar in tandem use of antisense application and the 14C iodoantipyrine technique we will determine the reciprocal effects of the receptors and their antgonist on each other and respective affect on the microcirculation after TBI. Histological and motor behavior studies will be used to assess neurological outcome following the therapeutic interventions. The results will provide valuable information on the expression of endothelin receptors (mRNA and proteins), their cellular distribution and the causal relationships of this expression to the alterations in the brain microcirculation after TBI. Precise times of ET- RA and ET- RB expressions will be established that should allow us to establish effective therapeutic interventions. The study will also provide direct evidence on the therapeutic value of suppressing gene regulation or receptor activation on cortical perfusion, histologic or neurologic injury, and its effect on impaired motor skills after TBI.
描述(由申请人提供):脑创伤后的一个重大事件是脑微血管的自动调节能力丧失,导致持续下降灌注和不当将重要代谢物传递到脑组织。以前,我们确定创伤后的持续下降灌注和缺乏自动调节能力的原因很大程度上是由于血管壁中受伤的细胞的能力以及其他大脑隔室在合成和维持过多量的内皮素-1(ET-1)的能力。 ET-1及其两个同工型ET-2和ET-3,通过其唯一已知的受体ET-RA和ET-RB发挥信号传递,血管收缩效应。尽管已知两种受体的激活都会在体外制剂和非神经组织中引起血管收缩,但对它们在受伤的大脑中的作用和继发性细胞损伤的发展知之甚少。实际上,从未研究过ET-RA和ET-RB在血管收缩及其药理操作中的作用,以防止创伤性脑损伤后细胞损伤(TBI)。 我们提出,在平滑肌和内皮中(最多表达它们)以及其他血管周围细胞中编码的基因编码为ET-RA和ET-RB合成的基因,这是TBT后在微血管壁中观察到的增强的收缩力。在该提议中,我们的具体目的是:1)在及时定量表征ET-ra和et-rb(mRNA)在血管壁的不同细胞室中的表达以及TBI之前和之后的神经纤维的不同细胞室的表达,2)翻译抑制Et-ra和Et-rb的TBI的表达,并在脑中的表达抑制了责任的脑中的表达,并在3)中受到了3)的表达。选择性拮抗剂的应用到ET-RA和ETBB。 我们将利用原位杂交来测量mRNA合成和体内脑室内施用反义寡脱氧核苷酸来减轻ET-ETRA和ET-RB基因表达。”在统一使用14ciodoantipyrine技术的统一使用中,我们将对植物的使用conterical cortoral cort and tandem使用选择性受体拮抗剂,从而对统一的植物进行抗衡。应用和14C碘氨基吡啶技术我们将确定受体及其对彼此的互惠效应,并在组织学和运动行为研究后对微循环的各个影响。 结果将提供有关内皮素受体(mRNA和蛋白质)表达,其细胞分布以及该表达与TBI后脑微循环改变的因果关系的有价值信息。将确定ET-RB表达式的精确时间,以使我们能够建立有效的治疗干预措施。该研究还将直接证明抑制基因调节或受体激活对皮质灌注,组织学或神经系统损伤的治疗价值及其对TBI后运动技能受损的影响。

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Alterations in cerebral cortex microvessels and the microcirculation in a rat model of traumatic brain injury: a correlative EM and laser Doppler flowmetry study.
创伤性脑损伤大鼠模型中大脑皮层微血管和微循环的改变:相关电磁和激光多普勒血流测定研究。
  • DOI:
    10.1179/016164107x204648
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Rafols,JoseA;Kreipke,ChristianW;Petrov,Theodor
  • 通讯作者:
    Petrov,Theodor
Endothelin receptors A and B are expressed in distinct cellular compartments of rat hippocampus following global ischemia: an immunocytochemical study.
全局缺血后,内皮素受体 A 和 B 在大鼠海马的不同细胞区室中表达:一项免疫细胞化学研究。
  • DOI:
    10.1179/016164111x12881719352291
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Kreipke,ChristianW;Reynolds,ChristianA;Schafer,PatrickC;Schafer,Steven;Pirooz,Ryan;Rafols,JoseA
  • 通讯作者:
    Rafols,JoseA
Amelioration of hypoperfusion after traumatic brain injury by in vivo endothelin-1 knockout.
通过体内内皮素-1 敲除改善创伤性脑损伤后的低灌注。
Intracellular coexpression of endothelin-1 and inducible nitric oxide synthase underlies hypoperfusion after traumatic brain injury in the rat.
内皮素-1 和诱导型一氧化氮合酶的细胞内共表达是大鼠脑外伤后灌注不足的原因。
  • DOI:
    10.1016/j.neulet.2004.03.021
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Rafols,D;Steiner,J;Rafols,JA;Petrov,T
  • 通讯作者:
    Petrov,T
Subcellular redistribution of calponin underlies sustained vascular contractility following traumatic brain injury.
钙调蛋白的亚细胞重新分布是脑外伤后持续血管收缩的基础。
  • DOI:
    10.1179/016164107x166317
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Kreipke,ChristianW;Morgan,RandyL;Petrov,Theodor;Rafols,JoseA
  • 通讯作者:
    Rafols,JoseA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSE A RAFOLS其他文献

JOSE A RAFOLS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSE A RAFOLS', 18)}}的其他基金

Control of Microvascular Tone in Traumatic Brain Injury
创伤性脑损伤中微血管张力的控制
  • 批准号:
    7055387
  • 财政年份:
    2000
  • 资助金额:
    $ 33.2万
  • 项目类别:
CONTROL OF MICROVASCULAR TONE IN TRAUMATIC BRAIN INJURY
创伤性脑损伤中微血管张力的控制
  • 批准号:
    6531114
  • 财政年份:
    2000
  • 资助金额:
    $ 33.2万
  • 项目类别:
CONTROL OF MICROVASCULAR TONE IN TRAUMATIC BRAIN INJURY
创伤性脑损伤中微血管张力的控制
  • 批准号:
    6363960
  • 财政年份:
    2000
  • 资助金额:
    $ 33.2万
  • 项目类别:
Control of Microvascular Tone in Traumatic Brain Injury
创伤性脑损伤中微血管张力的控制
  • 批准号:
    7222661
  • 财政年份:
    2000
  • 资助金额:
    $ 33.2万
  • 项目类别:
CONTROL OF MICROVASCULAR TONE IN TRAUMATIC BRAIN INJURY
创伤性脑损伤中微血管张力的控制
  • 批准号:
    6086110
  • 财政年份:
    2000
  • 资助金额:
    $ 33.2万
  • 项目类别:

相似国自然基金

全麻药诱导新生动物神经细胞选择性凋亡的机制及对婴幼儿认知功能影响的临床多中心研究
  • 批准号:
    81730031
  • 批准年份:
    2017
  • 资助金额:
    290.0 万元
  • 项目类别:
    重点项目
长期使用鼻用糖皮质激素在变应性鼻炎中对嗅觉功能影响的病理机制研究和临床初探
  • 批准号:
    81670904
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
大鼠胚胎Leydig细胞提早凋亡致成年细胞异常发育机理与邻苯二甲酸酯的影响
  • 批准号:
    81601264
  • 批准年份:
    2016
  • 资助金额:
    17.5 万元
  • 项目类别:
    青年科学基金项目
RFRP-3对哺乳动物卵泡发育的影响及作用机制研究
  • 批准号:
    31672507
  • 批准年份:
    2016
  • 资助金额:
    63.0 万元
  • 项目类别:
    面上项目
复方聪耳胶囊及其拆方干预离体和在体AmAn中毒性耳蜗神经细胞凋亡形态学及相关因子影响机制研究
  • 批准号:
    81373700
  • 批准年份:
    2013
  • 资助金额:
    65.0 万元
  • 项目类别:
    面上项目

相似海外基金

A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
  • 批准号:
    10752276
  • 财政年份:
    2024
  • 资助金额:
    $ 33.2万
  • 项目类别:
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
  • 批准号:
    10644874
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
  • 项目类别:
Investigating the role of CSF production and circulation in aging and Alzheimer's disease
研究脑脊液产生和循环在衰老和阿尔茨海默病中的作用
  • 批准号:
    10717111
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
  • 项目类别:
Rusalatide Acetate (TP508) Mitigation Effect on Radiation Induced Keratopathy
醋酸鲁沙来肽 (TP508) 对放射诱发的角膜病变的缓解作用
  • 批准号:
    10605739
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
  • 项目类别:
Determining the Role of Bacterial Products on Neuronal Localization and Function in a Symbiotic Organ
确定细菌产物对共生器官神经元定位和功能的作用
  • 批准号:
    10647940
  • 财政年份:
    2023
  • 资助金额:
    $ 33.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了